Mark Zimmerman - Publications

2008-2013 Pharmacology University of Pittsburgh, Pittsburgh, PA, United States 

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Cramer JM, Zimmerman MW, Thompson T, Homanics GE, Lazo JS, Lagasse E. Deletion of Ptp4a3 reduces clonogenicity and tumor-initiation ability of colitis-associated cancer cells in mice. Stem Cell Research. 13: 164-71. PMID 24950307 DOI: 10.1016/j.scr.2014.05.004  0.36
2014 Zimmerman MW, McQueeney KE, Isenberg JS, Pitt BR, Wasserloos KA, Homanics GE, Lazo JS. Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility. The Journal of Biological Chemistry. 289: 5904-13. PMID 24403062 DOI: 10.1074/jbc.M113.480038  0.36
2013 Zimmerman MW, Homanics GE, Lazo JS. Targeted deletion of the metastasis-associated phosphatase Ptp4a3 (PRL-3) suppresses murine colon cancer. Plos One. 8: e58300. PMID 23555575 DOI: 10.1371/journal.pone.0058300  0.36
Show low-probability matches.